Bard (C.R.) Inc. (BCR)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q4 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 11,210 | 0.05 | |
| Q3 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 47.11% | 3,590 | 0.02 | |
| Q2 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 7,620 | 0.03 | |
| Q3 2016 | |||||
| ≡ | Thomas Gayner - Markel Group | Sell 100.00% | 9,000 | 0.06 | |
| Q4 2015 | |||||
| ≡ | Thomas Gayner - Markel Group | Add 125.00% | 5,000 | 0.03 | |
| Q3 2015 | |||||
| ≡ | Thomas Gayner - Markel Group | Buy | 4,000 | 0.02 | |
| Q4 2014 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Sell 100.00% | 34,000 | 0.75 | |
| Q3 2014 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Reduce 10.53% | 4,000 | 0.09 | |
| Q2 2014 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Add 26.67% | 8,000 | 0.18 | |
| Q1 2014 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Reduce 14.29% | 5,000 | 0.12 | |
| Q4 2013 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Reduce 14.63% | 6,000 | 0.13 | |
| Q3 2013 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Reduce 14.58% | 7,000 | 0.14 | |
| ≡ | ValueAct Capital | Sell 100.00% | 758,704 | 0.85 | |
| Q2 2013 | |||||
| ≡ | ValueAct Capital | Reduce 79.02% | 2,857,604 | 3.20 | |
| Q1 2013 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Buy | 48,000 | 0.89 | |
| ≡ | ValueAct Capital | Reduce 15.52% | 664,286 | 0.76 | |
| Q4 2012 | |||||
| ≡ | ValueAct Capital | Reduce 6.17% | 281,543 | 0.35 | |
| Q3 2012 | |||||
| ≡ | ValueAct Capital | Reduce 22.32% | 1,310,802 | 1.94 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.